Adel Noury, Stankovic Nenad, Cervantes Gerardo, Gindi Amira, Shawky Lamiaa Mohamed
Oral and Maxillofacial Surgery Specialist, Private Practice, Cairo, Egypt.
Doctor of Dental Surgery, Specialist of Cosmetology, Aesthetic Physician, Private Practice, Belgrade, Serbia.
J Cosmet Dermatol. 2025 May;24(5):e70221. doi: 10.1111/jocd.70221.
This study aimed to investigate the effects of hyaluronic acid rejuvenating complex, polycaprolactone, and their combination on skin wound healing, assessing their potential to accelerate tissue regeneration and optimize healing outcomes.
Forty eight Wistar Albino rats were randomly divided into four groups. Group 1 received hyaluronic acid rejuvenating complex injection, Group 2 received polycaprolactone injection, and Group 3 received a combination of both. Group 4 served as the control, undergoing incision without intervention. Skin biopsies were collected at baseline, day 7, and day 14 postincision. Wound healing was evaluated histologically using hematoxylin and eosin (H&E) and Masson's trichrome staining, focusing on epithelial thickness, collagen synthesis, and inflammatory cell infiltration.
The combination therapy group (Group 3) exhibited the most pronounced wound healing response, demonstrating significantly accelerated re-epithelialization, enhanced collagen deposition, and well-structured granulation tissue by days 7 and 14. Additionally, inflammatory cell infiltration was markedly reduced, indicating a faster transition from the inflammatory to the proliferative phase. Compared to single-agent treatments, the combined approach resulted in superior tissue remodeling and a more efficient healing process.
The dual administration of hyaluronic acid rejuvenating complex and polycaprolactone offers a synergistic effect, significantly enhancing skin wound healing compared to monotherapies. These findings highlight the potential of combination therapy as a promising strategy for improving wound repair and tissue regeneration in aesthetic and regenerative dermatology.
本研究旨在探讨透明质酸焕肤复合物、聚己内酯及其组合对皮肤伤口愈合的影响,评估它们加速组织再生和优化愈合结果的潜力。
48只Wistar白化大鼠随机分为四组。第1组接受透明质酸焕肤复合物注射,第2组接受聚己内酯注射,第3组接受两者的组合。第4组作为对照组,仅进行切口而不进行干预。在切口后基线、第7天和第14天采集皮肤活检样本。使用苏木精和伊红(H&E)以及马松三色染色进行组织学评估伤口愈合情况,重点关注上皮厚度、胶原蛋白合成和炎症细胞浸润。
联合治疗组(第3组)表现出最显著的伤口愈合反应,在第7天和第14天时显示出明显加速的上皮再形成、增强的胶原蛋白沉积以及结构良好的肉芽组织。此外,炎症细胞浸润明显减少,表明从炎症期到增殖期的过渡更快。与单药治疗相比,联合治疗方法导致更好的组织重塑和更有效的愈合过程。
透明质酸焕肤复合物和聚己内酯的联合给药具有协同作用,与单一疗法相比,显著增强了皮肤伤口愈合。这些发现突出了联合治疗作为一种有前景的策略在美容和再生皮肤病学中改善伤口修复和组织再生的潜力。